Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline
Nia JulianAugust 18, 2021
Facebook0 Twitter Pinterest0 0 Likes
Previous

Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer

Nia JulianAugust 20, 2021
Next

Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471

Nia JulianJuly 27, 2021

© 2020 Solasta Ventures. All Rights Reserved.